Mayo Clinic PET Radiochemistry Facility
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 200 1st St SW, Rochester, Minnesota (MN) 55905, United States (USA)
- Operations here
- manufacture
- FDA identifiers
- FEI 3009119769 · DUNS 080416065
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-09-24
- VAIDrug Quality Assurance2015-12-04
- VAIDrug Quality Assurance2015-08-03
- VAIBioresearch Monitoring2014-07-11
- VAIDrug Quality Assurance2012-03-15
Drugs this plant is listed as making
4 distinct drugs across 4 products name this site in their FDA label.
- ammonia n-13Mayo Clinic
- Choline C-11Mayo Clinic
- Fludeoxyglucose F-18Mayo Clinic
- sodium fluoride F 18Mayo Clinic
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.